InvestorsHub Logo
Followers 53
Posts 3355
Boards Moderated 0
Alias Born 10/26/2013

Re: antihama post# 1632

Wednesday, 03/22/2017 3:53:59 PM

Wednesday, March 22, 2017 3:53:59 PM

Post# of 3283

based on these findings, a PI volasertib/belinostat trial in patients with aggressive NHL is planned

It's NCT02875002 "Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas"

Sponsor:Yale University
Collaborators:Massey Cancer Center + Sidney Kimmel Comprehensive Cancer Center

Clin trials is still showing that it hasn't started recruiting yet but something to keep track of.